The study was done to evaluate the safety and clinical outcome of routine caesarean myomectomy. This was a prospective descriptive study done in Obstetrics & Gynaecology department of Khulna Medical College Hospital & Sadar Hospital, Satkhira and two private clinics in Khulna city. Over a period of 4 years from July, 2009 to June, 2013, twenty one cases of caesarean myomectomy were presented. Our technique comprised of infiltration of vasoconstritive agent (ceprecin) before nucleation of myoma, myoma cavity accomplished by using "U" stitches of myometrial closure, routine use of oxytocin in post operative period for 24 hours. It was seen in this study that the mean age of the patients was 31.7 years and most of the cases (71.43%) were primigravida. Caesarean myomectomy done in term pregnancy was 85.71%. Elective surgery was done in 85.71% and emergency surgery was 14.29%. Two leading indications for caesarean section were malpresentation/ abnormal lie in 42.85% and uterine fibroid in 23.81%. Fibroid in lower uterine segment for selective myomectomy was 61.90%. Maximum (21,65.63%) fibroids were removed from the lower uterine segment and 22 (68.75%) of the fibroids were between 5 cms to 10 cms in size. The morbidities encountered were anaemia with blood transfusion in 2 (9.52%) and post partum pyrexia in 1 (4.76%) patients. No woman needed hysterectomy. Caesarean myomectomy may be done routinely by experienced surgeon and routine use of vasopressin into myoma capsule to combat uterine atony & severe bleeding. DOI: http://dx.doi.org/10.3329/bmjk.v46i1-2.18232 Bang Med J (Khulna) 2013; 46 : 7-11

Background: Carcinoma cervix is a preventable disease. It runs a long preinvasive stage, such as Normal - CIN I - CIN II - CIN III - Cancer cervix. It can be prevented at early stage of development with proper diagnosis, treatment & follow up. A major portion of CIN I spontaneously regress but some need treatment. Obiective: The purpose of this study was to determine the frequency of abnormal colposcopic findings during the 1 year follow up period in patients of CIN I treated with cold coagulation, LEEP and expectant management. Materials and Methods: This retrospective study was conducted in colposcopic centre of Khulna medical college hospital, Khulna, Bangladesh from January 2018 to December 2019. After confirmation of CIN I, ladies were arranged in three groups according to their treatment modalities - Expectant management (group A), Cold coagulation (group B) & LEEP (group C). They were reexamined with colposcopy after 6 months, or after one year of first visit. Persistence or reappearance of CIN was assayed & correlation between colposcopic results during follow up of different groups was analysed. Results: Total 195 ladies were diagnosed colposcopically as CIN I. Of them 75 women were confirmed by histological examination. Among 75 ladies, 25 ladies received no treatment, grouped as group A. Forty ladies treated with cold coagulation falls in group B, whereas 10 ladies who treated with LEEP were grouped as group C. Distribution of age, parity, monthly income, education, marital age, age at first delivery was similar in different group. During follow up persistence of disease were found in 2(13.3%) ladies who did not receive any form of treatment, 3(10.7%) who were treated with cold coagulation (p value 0.333) and 1(12.5%) lady who received treatment with LEEP (p value 0.667), were not significant. Conclusion: Colposcopic surveillance without treatment appears reasonable in treating CIN I because of the high rate of spontaneous regression of CIN 1, but adherence to the follow up should be emphasized to the patients during the follow up visits. Bang Med J Khulna 2020: 53 : 8-12

No abstract